GCA is a disease characterised by inflammation of large and medium sized blood vessels.
An alternative name for this condition is “Temporal Arteritis” as the blood vessels in the temple area of the head (sides of the forehead) are commonly affected.
The giant cells referred to are specific collections of immune system cells seen in the areas of inflammation if a biopsy is performed.
This condition is one of the commonest forms of vasculitis.
It is more commonly seen in older patients and is seldom diagnosed below the age of 50.
Germany’s Tag der Selbsthilfe on 16 September highlights the important role of local self-help groups. Vasculitis International is connecting vasculitis SHGs across Germany, combining peer support close to home with wider cooperation, shared knowledge and patient advocacy.
This is the news we hoped we would not have to publish.
The European Commission has adopted its final decision and revoked the marketing authorisation for TAVNEOS® (avacopan) in the European Union and the European Economic Area.
Last week added another significant step to the avacopan story: on 29 June 2026, the New England Journal of Medicine retracted the original 2021 ADVOCATE article on Tavneos.
